Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0390
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.387
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.562
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.651
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.911
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:107m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:174m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.555
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.779
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.979
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.101
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.734
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.910
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0292
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0820
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.887
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.979
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.134
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.258
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.787
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.897
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.921
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0500
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.112
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.453
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.523
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.425
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.740
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0582
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0938
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
10f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.678
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.821
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.927
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0665
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.348
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.349
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0562
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.376
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.890
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.900
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.579
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
10f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.738
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.882
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:174m
|
|
|
NotProcessed |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:107m
|
|
|
NotProcessed |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.173
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.375
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.960
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0438
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.161
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.348
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0554
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.302
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0595
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.113
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
10f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.538
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.388
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.645
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.915
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0549
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.342
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.873
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0397
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.982
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.423
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.752
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.861
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
50f:40m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:40m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0252
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.730
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
10f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.802
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.238
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.798
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
5f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.989
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.125
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.142
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.580
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.268
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.644
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.432
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:107m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:174m
|
|
|
NotProcessed |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.138
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.277
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.542
|
Successful |
Vxntm1a(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.173
|
Successful |
Vxntm1a(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.513
|
Successful |
Vxntm1b(KOMP)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.647
|
Successful |